Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 7.500% 5/0
-
Number of holders
-
4
-
Total 13F principal, excl. options
-
5,075,000
-
Principal change
-
0
-
Total reported value, excl. options
-
$23,838,000
-
Price
-
$4.67
Significant Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q3 2016
4 filings reported holding 868459AB4 - SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q3 2016.
SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 has 4 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $5,075,000 of principal
.
Largest 4 bondholders include 683 Capital Management, LLC ($3,000,000 of principal), Tekla Capital Management LLC ($2,000,000 of principal), GOLDMAN SACHS GROUP INC ($50,000 of principal), and WELLS FARGO & COMPANY/MN ($25,000 of principal).
This table shows the top 4 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.